Hypoxia inducible NOD2 interacts with 3-O-sulfogalactoceramide and regulates vesicular homeostasis
© 2013..
BACKGROUND: Oxygen sensing in mammalian cells is a conserved signaling pathway regulated by hypoxia inducible factor type 1 (HIF-1). Inadequate oxygen supply (hypoxia) is common to many pathological disorders where autophagy plays an import role. The aim of this study was the identification and characterization of novel HIF-1 target genes that promote autophagy during hypoxia.
METHODS: Whole genome Chromatin Immune Precipitation from hypoxic HeLa cells was used to identify novel HIF-1 target genes. Hypoxia induced expression and transcription regulation was studied in wild type and HIF-deficient cells. siRNA silencing of candidate genes was used to establish their role during autophagy. Recombinant protein was used for screening immobilized glycosylated lipids to identify potential ligands.
RESULTS: We identified the Nucleotide Oligomerization Domain 2 (NOD2/CARD15) as a novel HIF-1 target and 3-O-sulfo-galactoceramide (sulfatide) and Mycobacterium sp. specific sulfolipid-1 as the first NOD2 ligands that both compete for binding to NOD2. Loss of NOD2 function impaired autophagy upstream of the autophagy inhibitor chloroquine by reducing the number of acidic vesicles. Inhibition of sulfatide synthesis elicited defects in autophagy similar to the NOD2 loss of function but did not influence NOD2-mediated NF-kB signaling.
CONCLUSIONS: Our findings suggest that the interaction of NOD2 with sulfatide may mediate the balance between autophagy and inflammation in hypoxic cells.
GENERAL SIGNIFICANCE: These findings may lead to a better understanding of complex inflammatory pathologies like Crohn's disease and tuberculosis where both NOD2 and hypoxia are implicated.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:1830 |
|---|---|
| Enthalten in: |
Biochimica et biophysica acta - 1830(2013), 11 vom: 23. Nov., Seite 5277-86 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nabatov, Alexey A [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 21.03.2014 Date Revised 26.11.2016 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bbagen.2013.07.017 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM229403999 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM229403999 | ||
| 003 | DE-627 | ||
| 005 | 20231224082100.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bbagen.2013.07.017 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0764.xml |
| 035 | |a (DE-627)NLM229403999 | ||
| 035 | |a (NLM)23880069 | ||
| 035 | |a (PII)S0304-4165(13)00320-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nabatov, Alexey A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hypoxia inducible NOD2 interacts with 3-O-sulfogalactoceramide and regulates vesicular homeostasis |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.03.2014 | ||
| 500 | |a Date Revised 26.11.2016 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2013. | ||
| 520 | |a BACKGROUND: Oxygen sensing in mammalian cells is a conserved signaling pathway regulated by hypoxia inducible factor type 1 (HIF-1). Inadequate oxygen supply (hypoxia) is common to many pathological disorders where autophagy plays an import role. The aim of this study was the identification and characterization of novel HIF-1 target genes that promote autophagy during hypoxia | ||
| 520 | |a METHODS: Whole genome Chromatin Immune Precipitation from hypoxic HeLa cells was used to identify novel HIF-1 target genes. Hypoxia induced expression and transcription regulation was studied in wild type and HIF-deficient cells. siRNA silencing of candidate genes was used to establish their role during autophagy. Recombinant protein was used for screening immobilized glycosylated lipids to identify potential ligands | ||
| 520 | |a RESULTS: We identified the Nucleotide Oligomerization Domain 2 (NOD2/CARD15) as a novel HIF-1 target and 3-O-sulfo-galactoceramide (sulfatide) and Mycobacterium sp. specific sulfolipid-1 as the first NOD2 ligands that both compete for binding to NOD2. Loss of NOD2 function impaired autophagy upstream of the autophagy inhibitor chloroquine by reducing the number of acidic vesicles. Inhibition of sulfatide synthesis elicited defects in autophagy similar to the NOD2 loss of function but did not influence NOD2-mediated NF-kB signaling | ||
| 520 | |a CONCLUSIONS: Our findings suggest that the interaction of NOD2 with sulfatide may mediate the balance between autophagy and inflammation in hypoxic cells | ||
| 520 | |a GENERAL SIGNIFICANCE: These findings may lead to a better understanding of complex inflammatory pathologies like Crohn's disease and tuberculosis where both NOD2 and hypoxia are implicated | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Autophagy | |
| 650 | 4 | |a CQ | |
| 650 | 4 | |a Chloroquine | |
| 650 | 4 | |a Hypoxia | |
| 650 | 4 | |a LRR | |
| 650 | 4 | |a MDP | |
| 650 | 4 | |a Mtb | |
| 650 | 4 | |a Muramyl dipeptide | |
| 650 | 4 | |a Mycobacterium tuberculosis | |
| 650 | 4 | |a NOD2 | |
| 650 | 4 | |a Nucleotide-binding oligomerization domain-containing protein 2 | |
| 650 | 4 | |a PRR | |
| 650 | 4 | |a SL-1 | |
| 650 | 4 | |a Sulfatide | |
| 650 | 4 | |a V-ATPase | |
| 650 | 4 | |a Vacuolar-type H(+)-ATPase | |
| 650 | 4 | |a Vesicle | |
| 650 | 4 | |a leucine rich repeats | |
| 650 | 4 | |a mycobacteria specific Sulfolipid-1 | |
| 650 | 4 | |a pathogen recognition receptors | |
| 650 | 7 | |a Glycolipids |2 NLM | |
| 650 | 7 | |a Hypoxia-Inducible Factor 1, alpha Subunit |2 NLM | |
| 650 | 7 | |a Ligands |2 NLM | |
| 650 | 7 | |a NF-kappa B |2 NLM | |
| 650 | 7 | |a NOD2 protein, human |2 NLM | |
| 650 | 7 | |a Nod2 Signaling Adaptor Protein |2 NLM | |
| 650 | 7 | |a Virulence Factors |2 NLM | |
| 650 | 7 | |a sulfolipid I |2 NLM | |
| 650 | 7 | |a 53580-08-8 |2 NLM | |
| 700 | 1 | |a Hatzis, Pantelis |e verfasserin |4 aut | |
| 700 | 1 | |a Rouschop, Kasper M A |e verfasserin |4 aut | |
| 700 | 1 | |a van Diest, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Vooijs, Marc |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biochimica et biophysica acta |d 1948 |g 1830(2013), 11 vom: 23. Nov., Seite 5277-86 |w (DE-627)NLM000000698 |x 0006-3002 |7 nnns |
| 773 | 1 | 8 | |g volume:1830 |g year:2013 |g number:11 |g day:23 |g month:11 |g pages:5277-86 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bbagen.2013.07.017 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 1830 |j 2013 |e 11 |b 23 |c 11 |h 5277-86 | ||